Establishment of polarized cell morphology is a critical factor for migration and requires precise spatial and temporal activation of the Rho GTPases. Here, we describe a novel role of the actin-binding ezrin/radixin/moesin (ERM)-protein ezrin to be involved in recruiting Cdc42, but not Rac1, to lipid raft microdomains, as well as the subsequent activation of this Rho GTPase and the downstream effector p21-activated kinase (PAK)1, as shown by fluorescence lifetime imaging microscopy. The establishment of a leading plasma membrane and the polarized morphology necessary for random migration are also dependent on ERM function and Cdc42 in motile breast carcinoma cells. Mechanistically, we show that the recruitment of the ERM-interacting Rho/Cdc42-specific guanine nucleotide exchange factor Dbl to the plasma membrane and to lipid raft microdomains requires the phosphorylated, active conformer of ezrin, which serves to tether the plasma membrane or its subdomains to the cytoskeleton. Together these data suggest a mechanism whereby precise spatial guanine nucleotide exchange of Cdc42 by Dbl is dependent on functional ERM proteins and is important for directional cell migration.
INTRODUCTION
The ezrin/radixin/moesin (ERM) family of proteins are involved in regulation of cellular morphology and migration, and a direct interaction with actin filaments provides a regulatory link between the cytoskeleton and the cell membrane (Crepaldi et al., 1997; Lamb et al., 1997; Bretscher et al., 2002) . Activation of ERM proteins occurs by conformational changes triggered by binding of phosphatidylinositol 4,5-biphosphate (PIP 2 ) to the FERM (band 4.1, ERM) domain in the NH 2 -terminal region, termed the NH 2 -terminal ERM-associated domain (N-ERMAD) and phosphorylation of a conserved threonine residue (ezrin-T567, radixin-T564, moesin-T558) in the COOH-terminal domain, termed the COOH-terminal ERMassociated domain (C-ERMAD; Pietromonaco et al., 1998; Barret et al., 2000; Ng et al., 2001; Fievet et al., 2004) . This sequence of molecular events releases the intramolecular interaction between the N-and C-termini. Several kinases, including myotonic dystrophy kinase-related Cdc42-binding kinase Several kinases, including myotonic dystrophy kinase-related Cdc42-binding kinase (Nakamura et al., 2000) , protein kinase C␣ (Ng et al., 2001) , and Nck-interacting kinase (Baumgartner et al., 2006) have been shown to phosphorylate the conserved C-terminal threonine in ERM proteins. This second activation step of phosphorylation may restrict actin tethering by ERM proteins to specialized membrane domains, such as the protruding cell membranes, by locally unmasking the binding site for actin filaments in C-ERMAD. These changes in the ERM proteins also expose binding sites in N-ERMAD for plasma membrane receptors and scaffold proteins including CD44, CD43, ICAMs, and EBP50 (Reczek et al., 1997; Yonemura et al., 1998; Legg et al., 2002) . It is not clear however whether the affinity or availability of binding sites of N-ERMAD for these protein partners are affected by C-ERMAD binding (Chambers and Bretscher, 2005) . Establishment of polarity is essential for directed cell motility and requires localization of sensory and signaling molecules to the leading edge of a migrating cell. One such family of molecules are the small Rho GTPases, in partic-ular Cdc42 and Rac (Etienne-Manneville and Hall, 2002; Ridley et al., 2003) . The activation of Cdc42 and Rac1 is essential for protrusion and formation of filopodia and lamellipodia in eukaryotic cells, via the reorganization of the actin cytoskeleton, which leads to changes in cell morphology and migration (Kozma et al., 1995; Nobes and Hall, 1995; Leung et al., 1998) . Cdc42 is found in its active GTP-bound state at the leading edge of migrating cells (Itoh et al., 2002) , and inactivation of Cdc42 inhibits cell polarization and lamellipodial protrusions (Nobes and Hall, 1999) . Recently it has been shown that the GTP-bound Rac1 localizes preferentially to the low density, cholesterol-and caveolin-enriched membranes in human fibroblasts (del Pozo et al., 2004) . Furthermore, in cells detached from the extracellular matrix, endogenous Rac1 is recruited to cholera toxin subunit B (CTxB)-clustered lipid raft microdomains. This enables the sustained activation of p21-activated kinase (PAK) 1, a downstream effector of Rac and Cdc42 (del Pozo et al., 2004) . The lipid raft microdomain has therefore been proposed as a preferential membrane site for active GTPases, but the mechanisms by which these molecules are recruited to and more importantly, activated at these specific microdomains, are not well understood. In addition to membrane targeting, the activity of Rho GTPases is regulated by guanine nucleotide exchange factors (GEFs), promoting the exchange of GDP to GTP, and GTPase-activating proteins (GAPs), which stimulate the intrinsic GTPase activity upon binding to their respective GTPases. Currently there is limited information on the functional link between ezrin and Rho GTPase activation. Both the C-terminal threonine phosphorylated form of ERM and the phosphomimetic (T567D) ezrin mutant have been found to coprecipitate with Dbl in lymphocytes, in a complex that exhibits GEF activity toward RhoA in vitro (Lee et al., 2004) . The physiological effect of expressing T567D ezrin in these cells is an enhancement of uropod formation. On the basis of structurefunction analyses performed on the N-ERMAD, we have designed novel molecular tools that allow us to segregate the C-ERMAD-binding function of N-ERMAD from the latter's ability to associate with other protein ligands. Our data demonstrate that a mutant N-ERMAD of ezrin (which has a much reduced affinity to C-ERMAD) retains the ability to block cell migration as well as the lipid raft localization and activation of Cdc42, but not Rac1. Furthermore, we demonstrate that the conformational activation (phosphorylation) of ERM proteins is involved in the recruitment of the Cdc42/Rho-specific GEF Dbl to these microdomains, which acts as a potential mechanism for the spatial regulation of Cdc42 activity.
MATERIALS AND METHODS

Cell Culture and Transfection
Human breast carcinoma cells (MDA-MB-231) and human embryonic kidney (HEK)-293T cells were cultured in DMEM containing 10% fetal calf serum at 37°C, in an 5% CO 2 atmosphere. Cells were transfected using Fugene6 (Boehringer Mannheim, Indianapolis, IN) or calcium phosphate (Invitrogen, Carlsbad, CA) according to the protocol provided by the manufacturer. For Cdc42 small interfering RNA (siRNA), the 21-mer double-strand (dsRNA) sequences used were Cdc42-1: AAGTGGGTGCCTGAGATAACT, or Cdc42-2: AAA-GACTCCTTTCTTGCTTGT, or Nonsilencing control RNA interference (RNAi; Qiagen, Chatsworth, CA), and cells were transfected with 20 nM RNAi using HiPerfect (Qiagen) according to the protocol provided by the manufacturer.
Plasmid Constructs
cDNA containing VSV G-tagged full-length ezrin, ezrin(T567A), ezrin (T567D), and N-ERMAD were described previously (Algrain et al., 1993) . cDNAs containing GST-ezrin, GST-N-ERMAD, and GST-C-ERMAD were described previously (Andreoli et al., 1994) . E244K point mutation was generated using QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). The mRFP1 constructs were prepared by standard PCR amplification of full-length ezrin using 5Ј-CGTCGTAAGCTTAAAATGCCGAAACCA-3Ј and 5Ј-CGACGAATTCCACAGGGCCTCGAA-3Ј for full-length ezrin-mRFP1, and 5Ј-CGTCGTAAGCTTAAAATGCCGAAACCA-3Ј and 5Ј-CGACGAAT-TCCACTGGGCCTTCAT-3Ј for N-ERMAD-mRFP1. PCR products were cloned into pcDNA3.1-mRFP1 construct. GST-N-ERMAD(E244K) and N-ERMAD(E244K)-mRFP1 were generated as described above, using GST-N-ERMAD and N-ERMAD-mRFP1 as template. GST-Dbl(DH/PH) was subcloned into pGEX-KG from pRK5-myc-Dbl using BamHI. The PAK1-green fluorescent protein (GFP) construct was previously described (Parsons et al., 2005) . Onco-Dbl (pRK5-myc-Dbl) and FGD1 (pRK5-myc-FGD1) were generous gifts from Professor Alan Hall (MRC Laboratory for Molecular Cell Biology and Cell Biology Unit, London, United Kingdom). HA-Tiam1 (C1199) was a generous gift from Dr. John Collard (The Netherlands Cancer Institute, Amsterdam, The Netherlands). HA-p190RhoGEF was a generous gift from Dr. Wouter Moolenaar (National Cancer Institute), GST-RhoGDI was a generous gift from Dr. Alexis Gautreau (Institut Curie, Paris, France), Wt-Cdc42-GFP and V12Cdc42-GFP were provided by Dr. James Monypenny (Cancer Research UK London Research Institute, London). Cdc42-myc and N17Cdc42-myc was a generous gift from Dr. Julian Downward (Cancer Research UK London Research Institute).
Antibodies and Direct Conjugation to Fluorophores
Anti-VSVG and anti-myc (clone 9E10) monoclonal antibodies were generated at Cancer Research UK. The rabbit polyclonal anti-C-PERM antibody was obtained from Cell Signaling Technology (Beverly, MA). Rabbit polyclonal Dbl antibody (sc-89) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse mAb against Rac1 (23A8) was purchased from Upstate Biotechnology (Lake Placid, NY), and mouse mAb against Cdc42 was purchased from Chemicon International (Temecula, CA; MAB3707). Mouse mAb against ezrin was generated from recombinant full-length ezrin (2H3; Parsons and Ng, unpublished data) . For Fö rster resonance energy transfer (FRET) measurement, direct conjugation of IgG to the fluorophores Cy3 (Amersham Life Science, Piscataway, NJ) was performed as described previously .
Alexa Fluor-conjugated phalloidin was purchased from Molecular Probes (Eugene, OR).
Immunocytochemical Staining and Confocal Microscopy
Immunocytochemical stainings were performed as described elsewhere . Images were acquired on a confocal laser scanning microscope (model LSM 510 Meta, Carl Zeiss, Thornwood, NY) using a 63ϫ/1.4Plan-Apochromat oil immersion objective. Each image represents a single section in the Z-series, taken across the depth of the cell at 0.2-m intervals.
Raft Clustering by CTxB-coated Beads
Clustering of raft-associated ganglioside GM1 by CTxB beads was performed as previously described (del Pozo et al., 2004) . Briefly, cells were plated onto coverslips and left to adhere and spread for 24 h. For exogenous expression experiments, cells were microinjected with plasmids as indicated and allowed to express for 6 h. A solution of polystyrene 3-m beads coated overnight at 4°C with 10 g/ml CTxB (Calbiochem, La Jolla, CA) were added to cells for 20 min at 37°C. Cells were fixed in 4% paraformaldehyde and stained with antibodies as indicated and imaged on confocal microscope as described.
Protein Purification and In Vitro Pulldown Assays
Glutathione S-transferase (GST)-fusion proteins were expressed in Top10 Escherichia coli (Invitrogen) and affinity-purified using GST-agarose (Sigma, St. Louis, MO). C-ERMAD, RhoGDI, and Dbl(PH/DH) proteins were purified as GST-fusion proteins and enzymatically digested by thrombin to remove the GST according to protocols provided by the manufacturer (Amersham, Little Chalfont, Buckinghamshire, United Kingdom). Pulldown assays were performed by tumbling purified C-ERMAD, RhoGDI or Dbl(PH/DH) with GST, GST-N-ERMAD, or GST-N-ERMAD(E244K) bound to agarose beads. After extensive washes in lysis buffer, samples were resuspended in Laemmli sample buffer containing SDS. Cdc42 and Rac1 GTPase activity assays were performed as previously described (Parsons et al., 2005) using GST-PBD-PAK1. Rho GTPase activity assays were performed using GST-Rhotekin agarose (Upstate).
Protein Transduction using Chariot
Cells (grown on 3-cm tissue culture dishes to ϳ70% confluency) were transduced with purified proteins, as indicated, using Chariot (Active Motif Europe, Rixensart, Belgium) according to manufacturer's instructions. Briefly, 2 g of proteins were diluted in 100 l PBS and then added to 100 l H 2 O containing 6 l of the Chariot reagent. The Chariot:protein mix was left to stand in room temperature for 30 min before adding to cells in 400 l serum-free medium. After 1 h of incubation at 37°C, 1 ml of serum-containing medium was added to each dish. Cells were used for various assays (see Figures 2, 3 , and 10) after a further 30-min incubation. For ensuring equal transduction efficiencies, in parallel experiments, recombinant full-length (FL) ezrin (0.059 mg/ml), N-ERMAD (0.015 mg/ml), or N-ERMAD(E244K) (0.02 mg/ml) that were obtained from GST-fusion proteins after thrombin cleavage were labeled with Cy3 (Amersham Life Science) before being transduced into cells.
BIAcore Surface Plasmon Resonance Experiments
Immobilization of anti-GST on the CM5 sensor surface was performed according to the protocol provided by the manufacturer (GST Capture Kit, Biacore International, Switzerland) to a total of 4500 responsive units (RU) on a Biacore 3000 instrument (Biacore International, part of GE Healthcare UK Ltd., Little Chalfont, Buckinghamshire, United Kingdom). GST or GST-fusion proteins were captured on individual flowcells from soluble fraction of crude extracts from E. coli expressing the indicated fusion proteins after diluted 10 times in HBS buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% P20, 1 mM phenylmethylsulfonyl fluoride) injected at flow rate of 5 l/min for 200 s, generating a consistent 500 RU GST-fusion protein surface. After injection, surfaces were washed with HBS buffer for 600 s with a minimal baseline drift of 2-5 RU/min, before injection of purified C-ERMAD, RhoGDI, or Dbl(PH/DH), diluted in HBS to concentrations ranging from 5 nM to 2 M, with a flow rate of 30 l/min. Each surface was regenerated by two pulse-injections of 0.5% SDS BIAdesorb solution 1 (Biacore). Apparent K d s were calculated by global fit analysis or steady state affinity employing BIAevaluation 3.0 software after traces were baseline-corrected by subtraction of parallel control surface capturing GST alone.
Transwell Chamber Migration Analysis
Purified ezrin, N-ERMAD or N-ERMAD(E244K) proteins were transduced into MDA-MB-231 cells using Chariot according to the protocols provided by the manufacturer. After 90 min at 37°C, cells were trypsinized and replated into six-well (24-mm insert) transwell plates (Costar, Cambridge, MA) at a concentration of 5 ϫ 10 5 cells/well in DMEM containing 1% fetal calf serum (FCS). The bottom well in each case contained DMEM supplemented with 1% FCS and 1 M phorbol 12,13-dibutyrate (PDBu; Sigma), except for control wells, which contained 1% FCS alone. Cells were incubated for 8 h at 37°C, trypsinized separately from each top and bottom well, centrifuged at 1000 rpm, and fixed in 4% paraformaldehyde. Total numbers of cells in each chamber were counted using a CASY-1 cell counter (Sharfe System, GMbH, Reutingen, Germany) and migration was calculated as the percentage of cells in bottom chamber out of total number of cells, and an average from three individual wells per treatment was calculated in each experiment. Transmigration were normalized against control cells set at 100%.
Time-Lapse Analysis and Cell Tracking
Random migration of cells was assessed using time-lapse microscopy. Briefly, MDA-MB-231 cells were plated in 12-well dishes (Nunc, Naperville, IL) 24 h before recording in thermostatically controlled chamber (Solent Scientific Limited, Segensworth, United Kingdom) surrounding a Zeiss AxioVert 100 microscope using a 10ϫ phase-contrast objective and IQ software (Andor, Belfast, Northern Ireland). Images were captured using a Sensicam QE digital CCD camera (Cooke, Auburn Hills, MI). Frames were acquired every 5 min over a total period of 2 h. Analysis of speed was performed by manually tracking cells within each field over the sequence of time-lapse digital images (Motion Analysis Software, Andor, UK). The resultant cell tracks were analyzed using Mathematica software and comparisons between different groups of cell mean speed tracks were statistically assessed by analysis of variants (ANOVA).
FRET Determination by Multiphoton Fluorescence Lifetime Imaging Microscopy Measurements
Time-domain fluorescence lifetime imaging microscopy (FLIM) was performed with a multiphoton microscope system, comprising a solid-statepumped (8 W Verdi, Coherent, Palo Alto, CA), femtosecond self-modelocked Ti:Sapphire (Mira, Coherent) laser system, an in-house developed scan-head and an inverted microscope (Nikon TE2000E, Melville, NY) as described previously (Peter et al., 2005) . The presence/absence of FRET is determined by fitting of the experimental data to a single exponential decay. Significant reduction in the measured lifetime indicates FRET.
Immunoprecipitation and Western Blotting
MDA-MB-231 cells were transfected and/or treated as described in the text. Cells were lysed in modified RIPA buffer (1% (wt/vol) n-octyl-d-glucopyranoside, instead of NP-40) for 30 min at 4°C. Indicated antibodies were bound to protein A/G agarose beads (Autogen Bioclear UK Ltd., Calne, Wiltshire, United Kingdom), and the resulting bead solution was incubated with cell lysates overnight at 4°C. A sample of the "unbound" fraction was removed for analysis, and the beads were washed extensively in lysis buffer after binding. The precipitated proteins were denatured in sample buffer, separated on SDS-PAGE under reducing conditions, and transferred electrophoretically to nitrocellulose membrane (Amersham). Blots were probed with antibodies as specified.
RESULTS
Mutation of Glutamic Acid 244 in the N-ERMAD of Ezrin Decreases Its Binding to the C-ERMAD and Enhances Its Dominant Inhibition of Cell Migration
A number of studies have utilized the N-ERMAD of ERM proteins as dominant inhibitory constructs and demonstrated that the introduction of this domain alone can alter the function of endogenous ERM proteins, but the molecular mechanism whereby the N-ERMAD achieves dominant inhibition is hitherto poorly understood (Martin et al., 1995; Crepaldi et al., 1997; Amieva et al., 1999) . The N-ERMAD can either bind to receptors or scaffolding proteins at the plasma membrane, and thus abrogate binding of endogenous ERM proteins, or interacts directly with the C-ERMAD and thus altering the actin-binding capacities of endogenous ERM proteins. To separate the C-ERMAD-binding function of N-ERMAD from the latter's ability to associate with other protein ligands, we chose to generate a single mutation Glu244 to Lys (E244K) in the ezrin N-ERMAD, which is intended to modulate the hydrogen bonds between Glu244 and Arg570 in the helix D of the C-ERMAD, hence disrupting the N-ERMAD/C-ERMAD interface (Hamada et al., 2000; Pearson et al., 2000) . Using BIAcore surface plasmon resonance technology, we monitored the interaction between C-ERMAD and N-ERMAD. For this, we immobilized monoclonal anti-GST antibodies and by captured GST-N-ERMAD on the chip, we were able to assess the interaction between GST-N-ERMAD and C-ERMAD and obtain an estimated K d of 1.5 ϫ 10 Ϫ9 M for the N-ERMAD:C-ERMAD association ( Figure 1A ). As shown in Figure 1B , the N-ERMAD(E244K) showed a 400-fold decrease in the binding affinity toward C-ERMAD with a K d of 6 ϫ 10 Ϫ7 M compared with that of the wild-type (WT) N-ERMAD (K d of 1.5 ϫ 10 Ϫ9 M). We attempted to ascertain, using similar methodologies, the binding affinities of GST-N-ERMAD and N-ERMAD(E244K) toward purified Dbl(DH/PH) and Rho-GDI proteins. Unfortunately, the nonspecific binding of Dbl(DH/PH) to parallel control surface capturing GST alone was too high for us to estimate the specific binding of Dbl(DH/ PH) to the N-ERMADs. No binding of N-ERMAD(E244K) or (WT) N-ERMAD to purified Rho-GDI protein (up to 1 M) was seen by BIAcore analyses under similar experimental conditions (data not shown).
In addition, we analyzed the binding of the WT versus mutant GST-N-ERMAD (immobilized on beads) to purified C-ERMAD and Dbl protein preparations using an independent approach, namely GST pulldown followed by Western blot analysis. Immunodetection of C-ERMAD was achieved by in-house mAb 2H3 that specifically recognizes the Cterminus of ezrin (Parsons and Ng, unpublished data) . Despite the BIAcore analyses, which reproducibly showed the N-ERMAD(E244K) to have a substantially reduced affinity (K d of 6 ϫ 10 Ϫ7 M; in comparison to the binding of [WT] N-ERMAD to purified C-ERMAD; K d of 1.5 ϫ 10 Ϫ9 M), it was able to capture a similar amount of C-ERMAD after a prolonged incubation (overnight at 4°C), i.e., when the binding reaction has reached the equilibrium ( Figure 1D ). Similarly, at equilibrium, the in vitro binding of purified Dbl(PH/DH) to GST-N-ERMAD was not significantly affected by the E244K mutation ( Figure 1D ). The equivalent assay for Rho-GDI binding was not successful because the anti-Rho-GDI antibody we used had a high nonspecific binding to the GST itself (data not shown). The dominant inhibitory effect of N-ERMAD of ezrin on cell migration of several cell types has previously been described (Crepaldi et al., 1997; Sahai and Marshall, 2003) . We therefore tested the effect of the E244K mutation in N-ERMAD on migratory behavior of breast carcinoma cells by transducing recombinant proteins into MDA-MB-231 cells using Chariot. We measured the transduction efficiency of GSTtagged full-length ezrin, N-ERMAD, and N-ERMAD(E244K) and compared protein loading by immunoblotting. As shown in Figure 2A , GST-tagged full-length ezrin, N-ERMAD, and N-ERMAD(E244K) were transduced in similar amounts (GSTtagged full-length ezrin marked with *). Furthermore, to verify that the transduction efficiency was also equal in non-GSTtagged forms of the proteins (which were used in subsequent experiments), we transduced cells with thrombin-treated, Cy3-conjugated recombinant full-length ezrin, N-ERMAD, and N-ERMAD(E244K) and measured levels of Cy3 fluorescence in MDA-MB-231 cells after transduction. The mean fluorescent intensities (per field of view) of Cy3-conjugated full-length ezrin, N-ERMAD, and N-ERMAD(E244K) in these cells were 2.21 Ϯ 0.31, 1.98 Ϯ 0.38, and 2.43 Ϯ 0.70 (SEM for n ϭ 6 images, Figure 2B ), respectively, indicating that the recombinant proteins were transduced in equal amounts. Transduction of fulllength ezrin into MDA-MB-231 cells had no effect on the transmigration of cells toward the protein kinase C (PKC) activator PDBu (Ng et al., 1999; Legg et al., 2002) compared with cells treated with the Chariot alone ( Figure 2C ). Transduction of the N-ERMAD protein decreased MDA-MB-231 cell migration by 46.1%, whereas mutation of E244K in the N-ERMAD protein inhibited cell migration by 79.2% compared with the fulllength ezrin ( Figure 2C ). This demonstrates that introduction of an E244K mutation in the N-ERMAD enhances the dominant effects of N-ERMAD as evaluated by inhibition of PKCmediated cell migration. We also tested the effect of N-ERMAD and N-ERMAD(E244K) on the threonine phosphorylation of the C-ERMAD (C-PERM). Western blot analysis of cell lysates from untreated cells showed a basal level of C-PERM, and upon stimulating the cells with 1 M PDBu a 44.3 Ϯ 10.9% (SEM, n ϭ 3) increase in C-PERM was observed ( Figure 2D ). In contrast, upon transducing purified N-ERMAD or N-ERMAD (E244K) into MDA-MB-231 cells, the amount of C-PERM decreased substantially in untreated and cells treated with 1 M PDBu ( Figure 2D ). Furthermore, the N-ERMAD or N-ERMAD (E244K) both caused an inhibition of C-PERM, indicating a dominant inhibition of endogenous ERM protein activation. Confocal microscopy analyses demonstrate a clear decrease in the amount of endogenous ezrin in the periphery of N-ERMAD(E244K)-expressing cells compared with untransfected cells within the same field of view. Further, the phalloidin staining showed a clear increase in the amount of F-actin in the ruffles after PKC stimulation, which was reduced in the presence of ERMAD(E244K) (see Supplementary Figure S1 ). Together, these data indicate a molecular mechanism for dominant inhibition by N-ERMAD through interacting with ERMbinding molecules, in addition to the effect of direct binding to the C-ERMAD in endogenous ERM proteins.
N-ERMAD(E244K) Specifically Affects the Activity of the Small GTPase Cdc42
Members of the family of small GTPases Cdc42 and Rac have been shown to have a critical function in the control of the membrane protrusive activity and subsequently cell migration in a number of cell types (Raftopoulou and Hall, 2004) . We therefore examined the functional behavior of Cdc42 and Rac in MDA-MB-231 cells in the presence of full-length ezrin or N-ERMAD(E244K). Cells expressing PAK1-GFP and Cdc42-myc in the absence or presence of either full-length ezrin or N-ERMAD(E244K) were left unstained or were labeled after fixation with an anti-myc-Cy3 IgG and then subjected to multiphoton FLIM to measure FRET efficiency between GFP and Cy3 (Parsons et al., 2005) . The detection of FRET between a GFP donor and a Cy3 by FLIM requires a spatial separation between the fluorophores of no more than 9 nm (Bastiaens and Jovin, 1996) and results in a shortening of the GFP (donor) fluorescence lifetime (). In the unstained cells that coexpress full-length ezrin, the control average lifetime of PAK1-GFP alone was 2.26 ns (top left panels of Figure 3A ). In the presence of anti-myc-Cdc42 Cy3 acceptor, a significant reduction in GFP lifetime was observed, particularly in the peripheral cell protrusions (average ϭ 1.91 ns; FRET efficiency 15.8%; midleft panels, Figure 3A ). In the presence of N-ERMAD(E244K), the FRET efficiency between PAK1-GFP and anti-myc-Cdc42 Cy3 acceptor was significantly reduced (Eff ϭ 9.8%), demonstrating that the N-ERMAD(E244K) is altering the capacity of Cdc42 to interact with its downstream effector PAK1 (bottom left panels, Figure 3A ). The N-ERMAD(E244K) did not have any effect upon the FRET between PAK1-GFP and Rac1-myc-Cy3 (right panels, Figure 3A) , suggesting that the dominant inhibition of ERM function by N-ERMAD(E244K) specifically targets the activity of Cdc42. Biochemical PBD pulldown experiments demonstrated that the amount of GTP-bound Cdc42 in MDA-MB-231 cells was significantly reduced in the presence of N-ERMAD(E244K) compared with full-length ezrin (marked with an asterisk in Figure  3C ). In agreement with results from the FRET/FLIM analysis, the amount of GTP-bound Rac was unaffected by the presence of N-ERMAD(E244K) ( Figure 3C ). The amount of GTP-bound RhoA in MDA-MB-231 breast carcinoma cells (which do not form noticeable stress fibers or focal adhesions) is below the detection limit of GST-Rhotekin pulldown assays, irrespective of the presence of N-ERMAD(E244K) (data not shown). From these data we conclude that the presence of N-ERMAD(E244K) specifically disrupts the interaction of Cdc42 with its downstream effector PAK1 and decreases the GTP-bound fraction of Cdc42 without altering the activity of Rac1.
N-ERMAD(E244K) Alters the Migratory Potential of MDA-MB-231 Cells
To test the potential role of N-ERMAD(E244K) in regulating Cdc42-driven cell motility, we compared random migratory potential of MDA-MB-231 cells transduced with N-ERMAD (E244K) or transfected with RNAi against Cdc42. Transfection of siRNA against Cdc42 lead to Ͼ90% reduction in Cdc42 expression ( Figure 4A ), with no alterations in basal expression levels of endogenous Rac1 or HSP70. The substantial reduction in Cdc42 expression was consistently observed up to 64 h after transfection ( Figure 4A ). In random migration assays, control MDA-MB-231 cells exposed to Chariot alone were highly motile and exhibited a polarized morphology, with formation of lamellipodia in the direction of migration ( Figure 4B , top left panel). Quantitative analysis showed that the average speed of 26.5 Ϯ 0.9 m/h for control cells significantly decreased to 19.9 Ϯ 0.7 m/h (p Ͻ 0.001, n ϭ 95) for N-ERMAD(E244K)-transduced MDA-MB-231 cells, indicating that the presence of N-ERMAD(E244K) in cells changes the migratory behavior, possibly through altering the ability to adopt a polarized cell morphology. MDA-MB-231 control cells transfected with scramble siRNA showed similar phenotype as untransfected cells with an average speed of 25.9 Ϯ 1.0 m/h ( Figure 4C ), On knockdown of Cdc42 expression, the MDA-MB-231 cells showed a lack of polarized morphology and significantly reduced average cell speed of 15.9 Ϯ 1.7 m/h (in comparison to chariot alone control cells; Figure 4C ; p Ͻ 0.001, n ϭ 50), similar to that seen in cells transduced with N-ERMAD (E244K).
N-ERMAD(E244K) Inhibits the Recruitment of Cdc42 But Not Rac1 to Lipid Rafts
GM1-containing lipid rafts are involved in integrin-mediated localization of Rac1 and subsequent cell adhesion signaling (del Pozo et al., 2004) . Recent data have also detected the presence of ERM proteins in lipid rafts using mass spectrometry (Foster et al., 2003; Li et al., 2003) ; therefore we were interested to test whether ezrin could play a role in the activation of Cdc42 within these domains and indeed if the presence of N-ERMAD(E244K) affects the recruitment of Cdc42 to the lipid rafts via dominant inhibition of ERM proteins. Localized clustering of GM1-containing lipid rafts promoted by the CTxB-coated beads led to the recruitment of Cdc42, full-length ezrin, as well as recruitment of endogenous Rac1 to the lipid raft microdomains ( Figure 5 , top panels). However, in the presence of N-ERMAD(E244K), the recruitment of Cdc42 to the lipid rafts was completely abolished, although N-ERMAD(E244K) itself was localized to the beads ( Figure 5 , bottom panels). Recruitment of Rac1 to the CTxB-coated beads was unaltered in the presence of N-ERMAD(E244K) ( Figure 5 , bottom panels). These data demonstrate that N-ERMAD(E244K) inhibits the targeting of Cdc42 to lipid rafts, providing a potential mechanism for regulation of its activity, without affecting the recruitment of Rac1.
N-ERMAD(E244K) Disrupts the Morphological Reorganization Induced by onco-Dbl
Activation of small GTPases is catalyzed by GEFs responsible for the GDP-GTP exchange (review see Rossman et al., 2005) . As we identified a functional role of ERM proteins in the local recruitment and activation of Cdc42, we were interested to test the role of ERM proteins in modulating GEF activity and behavior. We analyzed the morphological changes in MDA-MB-231 cells after overexpression of a panel of GEFs: the Cdc42-specific Rho GEF FGD1 and the Cdc42/Rho-specific GEF onco-Dbl (Olson et al., 1996) ; the Rac-specific GEF Tiam1 (constitutively activated by an N-terminal deletion; Michiels et al., 1997) ; and the Rho-specific GEF p190RhoGEF (van Horck et al., 2001) . Expression of FGD1 in MDA-MB-231 cells induces formation of filopodia and membrane ruffles ( Figure 6A , top panel left). Coexpression of N-ERMAD(E244K) with FGD1 resulted in formation of filopodia, suggesting that N-ERMAD(E244K) is unable to inhibit the activation of Cdc42 induced by overexpression of FGD1 ( Figure 6A , top panel right). In the presence of onco-Dbl, an increase in membrane ruffling and lamellipodia spreading, similar to what was described previously (Olson et al., 1996) , is observed ( Figure 6A , middle panel right). In contrast, cells coexpressing both oncoDbl and N-ERMAD(E244K) rounded up and displayed no apparent ruffling ( Figure 6B , middle panel left), indicating that N-ERMAD(E244K) is altering the ability of onco-Dbl to stimulate lamellipodial spreading, although not sufficient to completely block morphological transformation by onco-Dbl as observed in rounding of the cells. The expression of the constitutive active form of Tiam1 (C1199) induced the formation of membrane ruffles as previously described (Michiels et al., 1997) , and cells expressing both Tiam1 (C1199) and N-ERMAD(E244K) showed a similar increase in lamellipodia formation ( Figure 6A Figure 6B ; p Ͻ 0.001, n ϭ 11 cells). Coexpression of N-ERMAD(E244K) alone, or in the presence of Tiam(C1199) or FGD1, showed no significant alteration in cell area ( Figure 6B) . Expression of the Rho-specific GEF p190RhoGEF in cells stimulated F-actin reorganization and the formation of stress fibers ( Figure 6C, top panel) , and the reorganization of F-actin was independent of the presence of N-ERMAD(E244K) (Figure 6C, bottom panel) . Together, these data indicate that N-ERMAD(E244K) specifically inhibits the morphological effect, i.e., lamellipodial spreading induced by an expression of onco-Dbl GEF activity, but not other GEFs such as FGD1, Tiam1, or p190RhoGEF.
To verify that these morphological changes were dependent on the activity of Cdc42, we coexpressed a constitutively active form of Cdc42 (V12Cdc42-GFP) together with onco-Dbl-myc and full-length ezrin-mRFP1 or N-ERMAD(E244K)-mRFP1. Expression of V12Cdc42 in the presence of onco-Dbl and fulllength ezrin did not alter the cellular morphology compared with onco-Dbl and full-length ezrin alone ( Figure 7A ). However, expression of V12Cdc42 in the presence of onco-Dbl and N-ERMAD(E244K) stimulated a dramatic increase in membrane ruffling and lamellipodial formation ( Figure 7A ), in contrast to the round morphology induced by coexpression of onco-Dbl and N-ERMAD(E244K) alone, demonstrating that a constitutively active form of Cdc42 has the ability to rescuethe inhibition of the onco-Dbl-induced phenotype by N-ERMAD(E244K). Quantification of pheno- types confirmed the V12Cdc42 rescue of membrane ruffling activity ( Figure 7B ). Moreover, coexpression of onco-Dbl and a dominant inhibitory form of Cdc42 (N17Cdc42) results in a rounded cell morphology similar to cells coexpressing onco-Dbl and N-ERMAD(E244K) (data not shown). To verify the Cdc42 dependency in Dbl-induced membrane ruffling, we examined the cell morphology in Cdc42 knockdown MDA-MB-231 cells. Expression of onco-Dbl in Cdc42 knockdown cells resulted in a rounded morphology, whereas the onco-Dbl expression in cells transfected with control siRNA induced formation of membrane ruffles (Figure 8 ), similar to cells expressing oncoDbl alone ( Figure 6A ). These experiments demonstrate that the cytoskeletal rearrangement controlled by Dbl can be prevented by expression of N-ERMAD(E244K) and suggest a functional role of ERM proteins in the regulation of Dbl GEF activity. Furthermore, data obtained using Cdc42-specific siRNA demonstrate a specific role of Cdc42 in the process of Dbl-dependent morphological rearrangement and thereby add functional evidence that corroborate our hypothesis that ERM proteins are critically involved in the Dbl-dependent regulation of Cdc42 activity.
Expression of N-ERMAD(E244K) Inhibits the Recruitment of Dbl to the Plasma Membrane
Activation of small GTPases by Rho GEFs is orchestrated by a combination of GDP/GTP exchange catalyzed by the Dblhomology (DH) domain and spatial membrane localization directed by the Pleckstrin-homology (PH) domain (reviewed by Rossman et al., 2005) . As ezrin has previously been shown to interact with Dbl via the PH domain (Vanni et al., 2004) , we analyzed the affects of N-ERMAD(E244K) on the subcellular localization of Dbl as a potential target for inhibiting Cdc42 activation. Endogenous Dbl is predominantly localized to the plasma membrane and in the cytoplasm overlapping with the localization of full-length ezrin ( Figure 9A ), similar to that reported previously (Vanni et al., 2004) . In the presence of N-ERMAD(E244K), the endogenous Dbl failed to be recruited to the plasma membrane and showed no colocalization with N-ERMAD(E244K) ( Figure 9A ). Analysis of recruitment to lipid raft microdomains in cells after incubation with CTxBcoated beads demonstrated a recruitment of endogenous Dbl, ezrin, and Rac1 to GM1-containing microdomains ( Figure 9B ). In contrast, when N-ERMAD(E244K) was expressed there was no recruitment of Dbl to the GM1-containing microdomains, whereas the localization of N-ERMAD(E244K) and Rac1 were detectable ( Figure 9B ). This demonstrates that the presence of N-ERMAD(E244K) inhibits the translocation of Dbl to the plasma membrane and to lipid raft microdomains, suggesting a requirement of functional ERM proteins for proper spatial localization of Dbl.
Activated Ezrin Restores the Plasma Membrane Targeting of Dbl in the Presence of N-ERMAD(E244K)
To identify the conformational requirement for ERM binding to endogenous Dbl, we performed immunoprecipitation experiments with the WT, the phosphomimetic (T567D), or the nonphosphorylatable (T567A) mutant form of ezrin and assessed the amount of Dbl that can be coprecipitated. These experiments showed an increased association of endogenous Dbl with ezrin(T567D) compared with WT ezrin, whereas no binding of Dbl to ezrin(T567A) was detected ( Figure 10A ). This demonstrates that ezrin associates with Dbl only in its open conformation. Furthermore, immunoprecipitation of endogenous ezrin from MDA-MB-231 cells revealed that a cocomplex including Dbl is formed in vivo ( Figure 10B ). Stimulation of cells by PDBu, which increases the amount of C-terminally phosphorylated ERM (as shown in Figure 2B ) was shown to increase the binding of Dbl to ezrin in MDA-MB-231 cells ( Figure 10B ). Transduction of purified N-ERMAD(E244K) into MDA-MB-231 cells, however, decreased the interaction between Dbl and ezrin that is induced by PKC activation ( Figure 10B ). We postulated that the N-ERMAD(E244K)-mediated inhibition of endogenous Dbl recruitment to the plasma membrane ( Figure 9A ) was caused by a dominant inhibition of C-terminal phosphorylation of endogenous ERM proteins and that this effect should be reversed by overexpression of the phosphomimetic (T567D) form of ezrin. This is demonstrated in Figure  10C where the coexpression of ezrin(T567D), rather than the nonphosphorylatable (T567A) form, when cotransfected with N-ERMAD(E244K) in a 2:1 ratio, was able to restore the localization of endogenous Dbl to the plasma membrane.
DISCUSSION
In previous studies, we have shown ezrin to be an important mediator of breast cancer cell migration (Ng et al., 2001 ) and a number of recent articles have highlighted the significant contribution of ezrin to the clinical development of metastasis in both osteosarcoma and rhabdomyosarcoma Yu et al., 2004; Elliott et al., 2005) . Mechanistically, ERM proteins have been implicated in the regulation of the Rho family of small GTPases either through inhibition of the Rho-specific GDP dissociation inhibitor RhoGDI (Takahashi et al., 1997) or through interaction with the Cdc42/Rhospecific guanine exchange factor Dbl (Vanni et al., 2004) . The functional consequence of the ERM-Dbl complex on Rho GTPase activity has to date however only been demonstrated for RhoA. For instance, in the context of uropod formation in lymphocytes, the C-terminal threonine-phosphorylated form of full-length ezrin was shown to associate with Dbl through its NH 2 -terminal domain and causes Rho activation (Lee et al., 2004) . Here we define a novel mechanism by which ezrin is important and necessary for spatial activation of Cdc42 in MDA-MB-231 cells. We observe that Dbl is recruited to GM1-positive microdomains in the plasma membrane in an ERM-dependent manner, and that onco-Dbl induced morphological changes are dependent on Cdc42 and functional ERM proteins. This suggests a mechanism whereby Dbl interacts with ezrin and/or other ERM proteins and is thereby recruited to the plasma membrane and to lipid raft microdomains, enabling a localized activation of Cdc42. Furthermore, these breast cancer cells do not have a detectable amount of GTP-bound RhoA and do not ordinarily form stress fibers or focal adhesions. The effect of N-ERMAD(E244K), through an abrogation of endogenous ERM-Dbl association, is therefore likely to be specific via a down-regulation of Cdc42 activity.
Previous experiments detected ERM proteins in lipid rafts using quantitative proteomic mass spectrometry analyses (Foster et al., 2003; Li et al., 2003) . Using density gradient fractionation techniques and caveolin as a lipid raft marker, we found only a small fraction of endogenous ezrin to localize to the fractions that contain caveolin (#6-#8; Supplementary Figure S2 ). The low percentage of total ezrin residing in lipid rafts at any one time makes relatively insensitive biochemical techniques such as sucrose gradient fractionation unsuitable for a quantitative analysis of changes in distribution.
On the basis of structure-function analyses and BIAcore assays, we have modified the dominant inhibitory strategy, which is based on ezrin N-ERMAD, and created a point mutant (E244K) that has an impaired ability to bind to the C-ERMAD. This mutated N-ERMAD domain retains the ability to inhibit PKC-mediated cell migration in a dominant negative manner. Notably, the C-terminal threonine phosphorylation of endogenous ERM induced by phorbol ester was inhibited by both N-ERMAD and N-ERMAD(E244K) despite the 400-fold reduction of N-ERMAD:C-ERMAD affinity caused by the point mutation. Hence, for the first time, we have demonstrated that the functional inhibition by the N-ERMAD domain is enhanced despite a decreased association with endogenous ERM proteins. As both N-ERMAD and N-ERMAD(E244K) locate at the plasma membrane, we postulate that the decrease in N-ERMAD:C-ERMAD association increases the availability of N-ERMAD(E244K) and that the dominant inhibition is instead achieved by abrogating the interaction between endogenous ERM and various N-ERMAD-interacting partners that are involved in the conformational activation of ERM proteins (Fievet et al., 2004; reviewed in Bretscher et al., 2002) . The T567D form rescues because it does not require the activation machinery, i.e., it is already in the open conformation to bind to Dbl at the right location, where the membrane is locally tethered to the cytoskeleton. Potential N-ERMAD-interacting partners that contribute to the activation process include the various protein kinases that phosphorylate the conserved C-terminal threonine (myotonic dystrophy kinaserelated Cdc42-binding kinase [Nakamura et al., 2000] , protein kinase C␣ [Ng et al., 2001] , and Nck-interacting kinase [Baumgartner et al., 2006] ) as well as the phosphoinositide PIP 2 (Fievet et al., 2004) . PIP 2 (IP 3 head) binding was shown to require several lysine residues from subdomains A and C of N-ERMAD, which form the positively charged molecular surface to interact with the negatively charged membrane inositol polyphosphates and, in the absence of PIP 2 , moesin does not bind CD44 in vitro (Hamada et al., 2000) . Although the effect of the E244K on PIP 2 binding was not formally tested, the non-PIP 2 -binding mutated (K253/254N, K262/263N) form of ezrin N-ERMAD was shown to be restricted to the cytoplasm, an effect that we did not observe with the E244K mutation. The identification of the precise binding protein that is "titrated" away by the N-ERMAD(E244K) will be the subject of further investigation.
Expression of N-ERMAD(E244K) resulted in a decrease of Cdc42 recruitment to lipid rafts. This was in addition to a decrease in the localized association of Cdc42 with its downstream effector PAK, and a global reduction in ac- tive, GTP-bound Cdc42. No changes were observed in the closely related GTPase Rac1, which led us to further investigate specific GEFs involved in regulation of GTPase activity. We identified Dbl as an upstream activator and exchange factor specific to Cdc42 in MDA-MB-231 cells, which was partially inhibited by the presence of N-ERMAD(E244K). Coexpression of N-ERMAD(E244K) could not reverse the phenotype after expression of oncoDbl or mimic the phenotype of N-ERMAD(E244K) expression alone, possibly due to the much enhanced activity state and the decrease in protein turnover of onco-Dbl when compared with the endogenous proto-Dbl (Ron et al., 1989; Kamynina et al., 2007) . Conversely, no changes were detected when analyzing the cell morphology induced by Cdc42-specific FGD1, Rac-specific Tiam1, or Rho-specific p190RhoGEF, in the absence or presence of N-ERMAD(E244K). Here we report that the morphological changes induced by onco-Dbl are dependent on the downstream effector Cdc42, and notably, the function of ERM proteins.
N-ERMAD(E244K) expression inhibits both the correct spatial recruitment of Dbl to the plasma membrane as well as the lipid raft recruitment and activation of Cdc42. Furthermore, in support of our hypothesis that the N-ERMAD(E244K)-mediated inhibition of endogenous Dbl recruitment to the plasma membrane was caused by a dominant inhibition of C-terminal phosphorylation of endogenous ERM proteins, this effect was shown to be reversed by overexpression of the phosphomimetic (T567D), rather than the nonphosphorylatable (T567A) form of ezrin. Together, these findings suggest that the active (i.e., C-terminally phosphorylated) form of ERM proteins, through forming a protein complex with Dbl, contributes toward Cdc42 activation in the correct subcellular localization, in response to promigratory signals. The activation of lipid raft localized Cdc42 (and its downstream effector PAK1; Krautkramer et al., 2004) in turn can stimulate rapid lipid raft patch accumulation (Golub and Caroni, 2005) and hence promote actin cytoskeleton accumulation and sustained protrusive activity at the leading edge.
Correct subcellular localization of activated species of GTPases is emerging as a common mechanism in the regulation of different dynamic cellular processes. Rap1 promotes cell spreading by localizing the Rac-specific GEFs VAV2 and Tiam1 to the plasma membrane and concurrent Rac1 activation (Arthur et al., 2004) . Moreover, inactivation of Rap1 can inhibit cell spreading promoted by constitutive active forms of VAV2 and Tiam1. This indicates that even the VAV2/Tiam1-promoted increase in Rac1 activity is not sufficient to promote cell spreading highlighting the significance of proper subcellular localization (Arthur et al., 2004) . In Saccharomyces cerevisiae, targeting of the Cdc42p-specific GEF Cdc24p to the incipient bud site is essential for the recruitment and activation of Cdc42p, and deletion of the Dbl-homology domain responsible for targeting Cdc24p to the budding site is lethal and unable to complement the growth defects of Cdc24⌬ cells (Ziman and Johnson, 1994; Toenjes et al., 1999; Shimada et al., 2004) . This indicates an evolutionarily conserved mechanism for proper localized GTPase activation. In the work presented here, we suggest a similar mechanism whereby ERM proteins are involved in the activation of Cdc42 in lipid raft microdomains at the leading edge of migrating cancer cells, via recruitment of the Cdc42/Rho-specific GEF Dbl.
